PGD3 is the mediator of the antiaggregatory effects of the trienoic endoperoxide PGH3.
D000818:Animals; D001681:Biological Assay; D003839:Deoxyadenosines / Q000031:analogs & derivatives / Q000494:pharmacology; D016048:Dideoxyadenosine / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000502:physiology; D010974:Platelet Aggregation / Q000187:drug effects*; D011449:Prostaglandin Endoperoxides / Q000494:pharmacology*; D011453:Prostaglandins / Q000494:pharmacology*; D011457:Prostaglandins D / Q000494:pharmacology*; D011463:Prostaglandins H / Q000494:pharmacology*; D012669:Seminal Vesicles / Q000378:metabolism; D012756:Sheep
D003839:Deoxyadenosines; D011449:Prostaglandin Endoperoxides; D011453:Prostaglandins; D011457:Prostaglandins D; D011463:Prostaglandins H; D016048:Dideoxyadenosine; C021008:2',5'-dideoxyadenosine